260 related articles for article (PubMed ID: 20686035)
1. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys.
Ersching J; Hernandez MI; Cezarotto FS; Ferreira JD; Martins AB; Switzer WM; Xiang Z; Ertl HC; Zanetti CR; Pinto AR
Virology; 2010 Nov; 407(1):1-6. PubMed ID: 20797754
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults.
Zhang S; Huang W; Zhou X; Zhao Q; Wang Q; Jia B
J Med Virol; 2013 Jun; 85(6):1077-84. PubMed ID: 23588735
[TBL] [Abstract][Full Text] [Related]
4. Generation of an adenoviral vaccine vector based on simian adenovirus 21.
Roy S; Zhi Y; Kobinger GP; Figueredo J; Calcedo R; Miller JR; Feldmann H; Wilson JM
J Gen Virol; 2006 Sep; 87(Pt 9):2477-2485. PubMed ID: 16894185
[TBL] [Abstract][Full Text] [Related]
5. Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.
Pinto AR; Fitzgerald JC; Giles-Davis W; Gao GP; Wilson JM; Ertl HC
J Immunol; 2003 Dec; 171(12):6774-9. PubMed ID: 14662882
[TBL] [Abstract][Full Text] [Related]
6. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors.
McCoy K; Tatsis N; Korioth-Schmitz B; Lasaro MO; Hensley SE; Lin SW; Li Y; Giles-Davis W; Cun A; Zhou D; Xiang Z; Letvin NL; Ertl HC
J Virol; 2007 Jun; 81(12):6594-604. PubMed ID: 17428852
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Neutralizing Antibodies against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients.
Zhao H; Xu C; Luo X; Wei F; Wang N; Shi H; Ren X
Front Immunol; 2018; 9():335. PubMed ID: 29563911
[TBL] [Abstract][Full Text] [Related]
8. The effect of adenovirus-specific antibodies on adenoviral vector-induced, transgene product-specific T cell responses.
Small JC; Haut LH; Bian A; Ertl HC
J Leukoc Biol; 2014 Nov; 96(5):821-31. PubMed ID: 25082150
[TBL] [Abstract][Full Text] [Related]
9. Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product.
Xiang Z; Gao G; Reyes-Sandoval A; Cohen CJ; Li Y; Bergelson JM; Wilson JM; Ertl HC
J Virol; 2002 Mar; 76(6):2667-75. PubMed ID: 11861833
[TBL] [Abstract][Full Text] [Related]
10. Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development.
Cheng C; Wang L; Ko SY; Kong WP; Schmidt SD; Gall JGD; Colloca S; Seder RA; Mascola JR; Nabel GJ
Vaccine; 2015 Dec; 33(51):7344-7351. PubMed ID: 26514419
[TBL] [Abstract][Full Text] [Related]
11. A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Dicks MD; Spencer AJ; Edwards NJ; Wadell G; Bojang K; Gilbert SC; Hill AV; Cottingham MG
PLoS One; 2012; 7(7):e40385. PubMed ID: 22808149
[TBL] [Abstract][Full Text] [Related]
12. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.
Fitzgerald JC; Gao GP; Reyes-Sandoval A; Pavlakis GN; Xiang ZQ; Wlazlo AP; Giles-Davis W; Wilson JM; Ertl HC
J Immunol; 2003 Feb; 170(3):1416-22. PubMed ID: 12538702
[TBL] [Abstract][Full Text] [Related]
13. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vectors composed of subgroup B adenoviruses.
Sakurai F; Kawabata K; Mizuguchi H
Curr Gene Ther; 2007 Aug; 7(4):229-38. PubMed ID: 17969556
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and Cross-Reactivity of Rhesus Adenoviral Vectors.
Iampietro MJ; Larocca RA; Provine NM; Abbink P; Kang ZH; Bricault CA; Barouch DH
J Virol; 2018 Jun; 92(11):. PubMed ID: 29563285
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.
Barouch DH; Pau MG; Custers JH; Koudstaal W; Kostense S; Havenga MJ; Truitt DM; Sumida SM; Kishko MG; Arthur JC; Korioth-Schmitz B; Newberg MH; Gorgone DA; Lifton MA; Panicali DL; Nabel GJ; Letvin NL; Goudsmit J
J Immunol; 2004 May; 172(10):6290-7. PubMed ID: 15128818
[TBL] [Abstract][Full Text] [Related]
17. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
[TBL] [Abstract][Full Text] [Related]
18. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
19. The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Dicks MD; Guzman E; Spencer AJ; Gilbert SC; Charleston B; Hill AV; Cottingham MG
Vaccine; 2015 Feb; 33(9):1121-8. PubMed ID: 25629523
[TBL] [Abstract][Full Text] [Related]
20. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.
Abbink P; Lemckert AA; Ewald BA; Lynch DM; Denholtz M; Smits S; Holterman L; Damen I; Vogels R; Thorner AR; O'Brien KL; Carville A; Mansfield KG; Goudsmit J; Havenga MJ; Barouch DH
J Virol; 2007 May; 81(9):4654-63. PubMed ID: 17329340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]